Liu Ming

Liu Ming


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2014 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
TZTao Zhang
Tao Zhang
HCHong-Sheng Chen
Hong-Sheng Chen
LWLi-Feng Wang
Li-Feng Wang
MBMing-Han Bai
Ming-Han Bai
YWYi-Chong Wang
Yi-Chong Wang
LMLiu Ming
Liu Ming
Ellagic Acid Exerts Anti-proliferation Effects via Modulation of Tgf-Β/Smad3 Signaling in MCF-7 Breast Cancer Cells Smad3;SIS3;TGF-${\beta}$/Smad3 pathway;ellagic acid;chemoprevention;MCF-7breast cancer cells; Ellagic acid has been shown to inhibit tumor cell growth. However, the underlying molecular mechanisms remain elusive. In this study, our aim was to investigate whether ellagic acid inhibits the proliferation of MCF-7 human breast cancer cells via regulation of the TGF-${\beta}$/Smad3 signaling pathway. MCF-7 breast cancer cells were transfected with pEGFP-C3 or pEGFP-C3/Smad3 plasmids, and treated with ellagic acid alone or in combination with SIS3, a specific inhibitor of Smad3 phosphorylation. Cell proliferation was assessed by MTT assay and the cell cycle was detected by flow cytometry. Moreover, gene expression was detected by RT-PCR, real-time PCR and Western blot analysis. The MTT assay showed that SIS3 attenuated the inhibitory activity of ellagic acid on the proliferation of MCF-7 cells. Flow cytometry revealed that ellagic acid induced G0/G1 cell cycle arrest which was mitigated by SIS3. Moreover, SIS3 reversed the effects of ellagic acid on the expression of downstream targets of the TGF-${\beta}$/Smad3 pathway. In conclusion, ellagic acid leads to decreased phosphorylation of RB proteins mainly through modulation of the TGF-${\beta}$/Smad3 pathway, and thereby inhibits the proliferation of MCF-7 breast cancer cells.

1 July 2015 in Nutrition Research
Verified
Journal Article
Closed access
YWYichong Wang
Yichong Wang
CDChristopher Dacosta
Christopher Dacosta
WWWei Wang
Wei Wang
ZZZhigang Zhou
Zhigang Zhou
LMLiu Ming
Liu Ming
YBYongping Bao
Yongping Bao

1 January 2016 in Disease Markers
Verified
Journal Article
Open access
PDF file
JWJiufeng Wei
Jiufeng Wei
GLGuodong Li
Guodong Li
SDShuwei Dang
Shuwei Dang
YZYuhui Zhou
Yuhui Zhou
KZKai Zeng
Kai Zeng
LMLiu Ming
Liu Ming
Colorectal carcinoma (CRC) is one of the most prevalent malignant tumors worldwide. Screening and early diagnosis are critical for the clinical management of this disease. DNA methylation changes have been regarded as promising biomarkers for CRC diagnosis. Here, we map DNA methylation profiling on CRC in six CRCs and paired normal samples using a 450 K bead array. Further analysis confirms the methylation status of candidates in two data sets from the Gene Expression Omnibus. Receiver operating characteristic (ROC) curves are calculated to determine the diagnostic performances. We identify 1549 differentially methylated regions (DMRs) showing differences in methylation between CRC and normal tissue. Two genes (ADD2andAKR1B1), related to the DMRs, are selected for further validation. ROC curves show that the areas under the curves ofADD2andAKR1B1are higher than that ofSEPT9, which has been clinically used as a screening biomarker of CRC. Our data suggests that aberrant DNA methylation ofADD2andAKR1B1could be potential screening markers of CRC.

11 April 2017 in Oncology Reports
Verified
Journal Article
Open access
PDF file
YWYichong Wang
Yichong Wang
ZZZhigang Zhou
Zhigang Zhou
WWWei Wang
Wei Wang
LMLiu Ming
Liu Ming
YBYongping Bao
Yongping Bao
Aberrant neovascularization supports nutrients and the oxygen microenvironment in tumour growth, invasion and metastasis. Recapitulation of functional microvascular structures in vitro could provide a platform for the study of vascular conditions. Sulforaphane (SFN), an isothiocyanate, has been reported to possess chemopreventive properties. In the present study, the effects of SFN on cell proliferation and tubular formation have been investigated using endothelial cells (ECs) and pericytes in coculture. SFN showed a dose-dependent inhibition on the growth of ECs and pericytes with IC50 values 46.7 and 32.4 µM, respectively. SFN (5-20 µM) inhibited tube formation in a 3D coculture although a lower dose (1.25 µM) promoted 30% more endothelial tube formation than control. Moreover, SFN affected intercellular communication between ECs and pericytes via inhibition of angiogenic factor such as vascular endothelial growth factor (VEGF) expression in pericytes. However, the expression of its receptor (VEGFR-2) was found significantly increased in ECs. These effects were associated with downregulation of prolyl hydroxylase domain-containing protein 1 and 2 (PHD1/2) and activation of hypoxia-inducible factor-1 (HIF) pathway by SFN. Furthermore, thioredoxin reductase-1 was also upregulated by SFN treatment, suggesting that anti-oxidant and redox regulation are involved in angiogenesis. Taken together, the results of the present study suggest that SFN differentially regulates endothelial cells and pericytes disrupting their interplay through the VEGF-VEGFR signalling pathway. Anti-angiogenesis property of SFN indicates that it has potential role as an anticancer agent.

9 June 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
YWYichong Wang
Yichong Wang
JWJiufeng Wei
Jiufeng Wei
SZShujun Zhang
Shujun Zhang
GLGuodong Li
Guodong Li
TZTao Zhang
Tao Zhang
LMLiu Ming
Liu Ming

1 January 2018
Verified
Journal Article
Closed access
XYXin Yu
Xin Yu
ZFZhenhuan Fang
Zhenhuan Fang
GLGuodong Li
Guodong Li
SZShujun Zhang
Shujun Zhang
LMLiu Ming
Liu Ming
YWYing Wang
Ying Wang